Emergent BioSolutions Inc. (EBS)

NYSE: EBS · Real-Time Price · USD

Compare

10.04

+0.96 (10.57%)

At close: Nov 21, 2025, 4:00 PM EST

10.08

+0.04 (0.40%)

Pre-market: Nov 24, 2025, 5:37 AM EST

Emergent BioSolutions Market Cap

Emergent BioSolutions has a market cap or net worth of $527.3 million as of November 24, 2025. Its market cap has increased by 8.34% in one year.

Market Cap

527.30M

Enterprise Value

952.80M

1-Year Change

8.34%

Ranking

#2976

Market Cap Chart

Since November 15, 2006, Emergent BioSolutions's market cap has increased from $320.80M to $527.30M, an increase of 64.37%. That is a compound annual growth rate of 2.65%.

Market Cap History

Date	Market Cap	% Change
Nov 21, 2025	527.30M	1.80%
Dec 31, 2024	518.00M	316.06%
Dec 29, 2023	124.50M	-78.87%
Dec 30, 2022	589.20M	-74.81%
Dec 31, 2021	2.34B	-50.75%
Dec 31, 2020	4.75B	70.50%
Dec 31, 2019	2.79B	-7.78%
Dec 31, 2018	3.02B	57.00%
Dec 29, 2017	1.92B	44.63%
Dec 30, 2016	1.33B	-14.64%
Dec 31, 2015	1.56B	52.38%
Dec 31, 2014	1.02B	22.29%
Dec 31, 2013	836.10M	45.38%
Dec 31, 2012	575.10M	-5.00%
Dec 30, 2011	605.40M	-25.67%
Dec 31, 2010	814.50M	94.58%
Dec 31, 2009	418.60M	-46.42%
Dec 31, 2008	781.20M	419.07%
Dec 31, 2007	150.50M	-50.82%
Dec 29, 2006	306.00M	-4.61%
Nov 15, 2006	320.80M	-

View and export this data all the way back to 2006. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	948.84B
Johnson & Johnson	491.26B
AbbVie	417.60B
UnitedHealth Group	289.84B
AstraZeneca	280.49B
Novartis AG	243.93B
Merck & Co.	242.64B
Abbott Laboratories	222.77B

Market Cap Rankings